Middle Molecule Find

Rulebook › V-tags › V631

V631 QAPI area: mineral metabolism and renal bone disease

Written V0631 on the CMS-2567 and in QCOR.

Enforces 42 CFR 494.110(a)(2)(iii) · Appendix H Rev. 246, page 268 · checked 12 Nov 2026

Cited on this tag? What happens after a citation · One-page sheet for the binder

The regulation

§ 494.110 (a)(2) – The program must include, but not be limited to, the following: (iii) Mineral metabolism and renal bone disease.

Read 42 CFR 494.110 on the eCFR

CMS's interpretive guidance

Interpretive Guidance § 494.110(a)(2)(iii):

The intent of QAPI in addressing the management of CKD mineral and bone disorder is to maximize the number of patients who achieve the goals for this area. Refer to the Measures Assessment Tool (MAT), which lists the current professionally-accepted clinical practice standards in this and other areas.

Since this area is heavily influenced by patient diet, it is critical that patient education, encouragement, and support be included in improvement plans for this indicator. The IDT should evaluate the efficacy of any standardized CKD mineral and bone disorder guideline or algorithm in use if facility QAPI goals in this area are not achieved over consecutive evaluation periods and other factors (e.g., transfers, new admissions, hospitalizations, discharges, recent access surgeries, or acutely ill patients) are not responsible.

Verbatim from Appendix H Rev. 246, with CMS's headings, lists and bold. Check page 268 (the full 469-page PDF) before quoting it.